Association Between Concurrent Use of Amiodarone and DOACs and Risk of Bleeding in Patients With Atrial Fibrillation-Reference-Cited by-同舟云学术

Association Between Concurrent Use of Amiodarone and DOACs and Risk of Bleeding in Patients With Atrial Fibrillation

Published:2023-01 Issue: Volume:186 Page:58-65
ISSN:0002-9149
Container-title:The American Journal of Cardiology
language:en
Short-container-title:The American Journal of Cardiology

Author:

Shurrab Mohammed^ORCID,Jackevicius Cynthia A.,Austin Peter C.,Tu Karen,Qiu Feng,Singh Sheldon M.,Crystal Eugene,Caswell Joseph,Michael Faith,Andrade Jason G.,Ko Dennis T.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference34 articles.

1. Atrial fibrillation–the growing epidemic;Lip;Heart,2007

2. Temporal trends in the incidence, prevalence, and survival of patients with atrial fibrillation from 2004 to 2016;Williams;Am J Cardiol,2017

3. Epidemiology of atrial fibrillation in the 21st Century: novel Methods and New Insights;Kornej;Circ Res,2020

4. Trends and variation in oral anticoagulant choice in patients with atrial fibrillation, 2010–2017;Zhu;Pharmacotherapy,2018

5. Risk of hospitalization with hemorrhage among older adults taking clarithromycin vs azithromycin and direct oral anticoagulants;Hill;JAMA Intern Med,2020

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Apixaban vs rivaroxaban in patients with atrial fibrillation at high or low bleeding risk: A population-based cohort study;Heart Rhythm;2024-08

2. Potential interactions between medications for rate control and direct oral anticoagulants: Population-based cohort and case-crossover study;Heart Rhythm;2024-06

3. Comparative effectiveness and safety of apixaban and rivaroxaban in older patients with atrial fibrillation: A population-based cohort study;Heart Rhythm;2024-06

4. 2024 Chinese Expert Consensus Guidelines on the Diagnosis and Treatment of Atrial Fibrillation in the Elderly, Endorsed by Geriatric Society of Chinese Medical Association (Cardiovascular Group) and Chinese Society of Geriatric Health Medicine (Cardiovascular branch): Executive Summary;Thrombosis and Haemostasis;2024-05-14

5. The Price of Keeping the Rhythm: Increased Bleeding Risk in Patients With Atrial Fibrillation Concurrently Prescribed Amiodarone and Factor Xa Inhibitors;Journal of Cardiothoracic and Vascular Anesthesia;2023-12